BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

24 hedge funds and large institutions have $3.62M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
4
Calls
$537K
Puts
$436K
Net Calls
+$101K
Net Calls Change
-$186K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$293K
2
TRCT
2
Tower Research Capital (TRC)
New York
$270K
3
UBS Group
3
UBS Group
Switzerland
$29.8K
4
LWANC
4
Laurel Wealth Advisors (North Carolina)
North Carolina
$15.2K
5
MCM
5
MAI Capital Management
Ohio
$12.7K

Top Sellers

1
IMC Chicago
1
IMC Chicago
Illinois
$0
2
Jane Street
2
Jane Street
New York
$0
3
WWM
3
Westwood Wealth Management
California
$405K
4
TFA
4
Toth Financial Advisory
Virginia
$439K
5
Morgan Stanley
5
Morgan Stanley
New York
$9.99K
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
26
Jane Street
New York
– -$306K -4,803 Closed
Osaic Holdings
27
Osaic Holdings
Arizona
– -$19.1K -300 Closed
CIBC Private Wealth Group
28
CIBC Private Wealth Group
Georgia
– -$3.83K -60 Closed
1
2